← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleNektar TherapeuticsPhase 2

nivolumab (Opdivo, Dose Expansion Doublet: Combination of NKTR-214 + nivolumab)

Melanoma; Renal Cell Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 64%임상시험 1상태 ACTIVE
AntibodystaleNektar TherapeuticsPhase 2

nivolumab (Opdivo, Dose Expansion Triplet: Combination of NKTR-214+ nivolumab+ ipilimumab)

Melanoma; Renal Cell Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 64%임상시험 1상태 ACTIVE
AntibodystaleUniversity of Colorado, DenverPhase 1

durvalumab (Imfinzi, Dose Expansion of Durvalumab and Trabectedin)

Solid Tumor, Adult · Solid Tumor, Adult

#SolidTumorAdult#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 DISCONTINUED
AntibodystaleAgendiaApproved

trastuzumab (Herceptin, Dose dense AC followed by T + trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAgendiaApproved

trastuzumab (Herceptin, Dose dense AC followed by T + trastuzumab + pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAmsterdam UMC, location VUmcPhase 2

Dose escalation cetuximab (Dose escalation cetuximab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleUniversitaire Ziekenhuizen KU L…Phase 2

Dose escalation of cetuximab (Dose escalation of cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity Hospital, GhentApproved

adalimumab (Humira, Dose tapering of adalimumab in patients with supratheurapeutic serum trough levels)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleTesaro, Inc.Phase 3

TSR-042 (Dostarlimab, Dostarlimab (TSR-042))

Ovarian Neoplasms; Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma · Ovarian Neoplasms

#OvarianNeoplasms#Antibody#Phase3#항체#면역항체+4
효능 ORR 88%임상시험 1상태 RECRUITING
AntibodystaleUniversity of LeicesterPhase 2

Dostarlimab and Niraparib (Dostarlimab and Niraparib)

Mesothelioma, Malignant · Mesothelioma, Malignant

#MesotheliomaMalignant#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleTokyo UniversityPhase 3

Double-Blind Rituximab (Double-Blind Rituximab)

Scleroderma, Systemic; Skin Sclerosis · Scleroderma, Systemic

#SclerodermaSystemic#Antibody#Phase3#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, Double-blind adalimumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleQilu Hospital of Shandong Unive…Preclinical

Doublet or triplet chemotherapy combined with cetuximab (Doublet or triplet chemotherapy combined with cetuximab)

Colon Cancer · Colon Cancer

#ColonCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

adalimumab (Humira, Dovobet, neotigason, etanercept, adalimumab. infliximab)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 2

Doxorubicin and cyclophosphamide (AC, Doxorubicin and cyclophosphamide, Doxorubicin and cyclophosphamide (AC) + bevacizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

daratumumab (Darzalex, Dratumumab / Hyaluronidase Injection [Darzalex Faspro])

Light Chain (AL) Amyloidosis · Light Chain (AL) Amyloidosis

#LightChainALAmyloidosis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAkesoPhase 2

Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine (Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine)

Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleSichuan Kelun-Biotech Biopharma…Phase 1

Drug: Tagitanlimab Drug: Capecitabine (Drug: Tagitanlimab Drug: Capecitabine)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Drug: Tislelizumab, Cetuximab, Cisplatin and Nab-paclitaxel (Drug: Tislelizumab, Cetuximab, Cisplatin and Nab-paclitaxel)

Oral Squamous Cell Carcinoma (OSCC); Oropharyngeal Squamous Cell Carcinoma (SCC) · Oral Squamous Cell Carcinoma (OSCC)

#OralSquamousCellCarcinomaOSCC#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Drug: XS-03, Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI (Drug: XS-03, Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI)

Colorectal Cancer; Metastatic Colorectal Cancer With RAS Mutation · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE

41 / 92 페이지

← 이전다음 →